Applications have opened for a national accelerator programme supporting data-driven health innovation. 

KQ Labs, led by the Francis Crick Institute and Medicines Discovery Catapult (MDC), is an annual five-month programme for early-stage companies building science-backed, scalable solutions in AI-driven drug discovery, digital health, and precision medicine. 

Up to 10 high-potential companies will receive weekly workshops, expert mentoring, office hours with leading pharmaceutical companies and investment funds, alongside support with fundraising strategy, helping them de-risk their ideas and build investment-ready businesses. 

According to MDC, the first 70 startups supported by the KQ Labs core programme have collectively raised over £230 million ($308 million) in investment since the programme’s launch in 2018. MDC joined as a strategic partner in 2025. 

“The UK has world-class talent exploring the application of advanced computational techniques to treat the most challenging diseases,” said Dr Nicola Heron, Chief Strategy Officer at Medicines Discovery Catapult. 

“KQ Labs exists to give that talent the support, networks, and commercial rigour needed to realise their potential.  

“A year into our partnership with the Crick, we have seen first-hand what this programme unlocks for early-stage companies, and our team at MDC is energised to support the next cohort of inspiring innovators in pushing the boundaries of possibility.” 

“Over eight years, KQ Labs has nurtured some of the most exciting data-driven health founders and technologies, spanning tools and platforms for drug discovery and development, precision medicine, and digital health,” added Jo Mills, Head of Entrepreneurship and KQ Labs at the Francis Crick Institute. 

“Ongoing support from Medicines Discovery Catapult and Cancer Research Horizons will enable us to continue this mission and continue to evolve our curated ecosystem of mentors and investors, who together provide the inspiration, expertise and connections for our portfolio of early-stage ventures to succeed.”